Abstract
>Nitric oxide (NO) is an ubiquitous signaling molecule produced from L-arginine by NO synthase (NOS). In the vasculature, NO mediates parasympathetic endothelium-dependent vasodilation. NO may also mediate the parasympathetic control of myocardial function1. This is supported by the observations that NOS3, the endothelial constitutive NOS, is expressed in normal cardiac myocytes from rodents2 and human3, and NOS and/or guanylyl cyclase inhibitors antagonize the effect of muscarinic agonists on heart rate4,5, atrio–ventricular conduction6, contractility2,4,7 and L-type calcium current1,2,5,6. Here we examine the autonomic regulation of the heart in genetically engineered mice deficient in NOS3 (NOS3-KO)(ref. 8). We show that the chronotropic and inotropic responses to both β-adrenergic and muscarinic agonists were unaltered in isolated cardiac tissue preparations from NOS3-KO mice, although these mice have a defective parasympathetic regulation of vascular tone8,9. Similarly, β-adrenergic stimulation and muscarinic inhibition of the calcium current did not differ in cardiac myocytes from NOS3-KO mice and those from wild-type mice. RT–PCR did not demonstrate upregulation of other NOS isoforms. Similarly, Gi/Go proteins and muscarinic receptor density were unaltered. These data refute the idea that NOS3 is obligatory for the normal autonomic control of cardiac muscle function10.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kelly, R.A., Balligand, J.L. & Smith, T.W. Nitric oxide and cardiac function. Circulation 79, 363–380 ( 1996).
Balligand, J.L. et al. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J. Biol. Chem. 270, 14582–14586 (1995).
Wei, C.M., Jiang, S.W., Lust, J.A., Daly, R.C. & McGregor, C.G.A. Genetic expression of endothelial nitric oxide synthase in human atrial myocardium. Mayo Clin. Proc. 71, 346–350 (1996).
Balligand, J.L., Kelly, R.A., Marsden, P.A., Smith, T.W. & Michel, T. Control of cardiac muscles cell function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. USA 90, 347–351 ( 1993).
Han, X., Shimoni, Y. & Giles, W.R. An obligatory role for nitric oxide in autonomic control of mammalian heart rate. J. Physiol. (Lond.) 476, 309–314 (1994).
Han, X., Kobzik, L., Balligand, J.L., Kelly, R.A. & Smith, T.W. Nitric oxide synthase (NOS3)-mediated cholinergic modulation of Ca2+ current in adult rabbit atrioventricular nodal cells. Circ. Res. 78, 998– 1008 (1996).
Hare, J. M. et al. Pertussis toxin-sensitive G proteins influence nitric oxide synthase III activity and protein levels in rat heart. J. Clin. Invest. 101, 1424–1431 ( 1998).
Huang, P.L. et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377, 239– 242 (1995).
Steudel, W. et al. Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS3) gene. Circ. Res. 81, 34–41 (1997).
Han, X. et al. Muscarinic cholinergic regulation of cardiac myocyte I Ca-L is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proc. Natl Acad. Sci. 95, 6510–6515 (1998).
Méry, P.-F. et al. Muscarinic regulation of the L-type calcium current in isolated cardiac myocytes. Life Sci. 60, 1113–1120 (1997).
Hare, J.M., Givertz, M.M., Creager, M.A. & Colucci, W.S. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: Potentiation of beta-adrenergic inotropic responsiveness. Circulation 97, 161–166 (1998).
Méry, P.-F., Hove-Madsen, L., Chesnais, J.-M., Hartzell, H.C. & Fischmeister, R. Nitric oxide synthase does not participate in negative inotropic effect of acetylcholine in frog heart. Am. J. Physiol. 270, H1178– H1188 (1996).
Vandecasteele, G., Eschenhagen, T. & Fischmeister, R. Role of the NO/cGMP pathway in the muscarinic regulation of the L-type Ca2+ current in human atrial myocytes. J. Physiol. (Lond.) 506, 653–663 (1998).
Kilter, H. et al. Evidence against a role of nitric oxide in the indirect negative inotropic effect of M cholinoceptor stimulation in human ventricular myocardium. Naunyn Schmiedebergs Arch. Pharmacol. 352, 308–312 (1995).
Hui, J., Tabatabaei, A. & MacLeod, K.M. L-NMMA blocks carbachol-induced increases in cGMP levels but not decreases in tension in the presence of forskolin in rabbit papillary muscles. Cardiovasc. Res. 30, 372–376 (1995).
Gallo, M.P. et al. Modulation of guinea-pig cardiac L-type calcium current by nitric oxide synthase inhibitors. J. Physiol. (Lond.) 506, 639–651 (1998).
Eschenhagen, T. et al. Chronic treatment with carbachol sensitizes the myocardium to cAMP-induced arrhythmias. Circulation 93, 763–71 (1996).
Wolska, B.M. & Solaro, R.J. Method for isolation of adult mouse cardiac myocytes for studies of contraction and microfluorimetry. Am. J. Physiol. 271, H1250–H1255 (1996).
Kleinert, H. et al. Estrogens increase transcription of the human endothelial NO synthase gene: analysis of the transcription factors involved. Hypertension 31, –582-588.
Acknowledgements
We thank P. Huang for providing the NOS3-KO mice, and M. Nose, J. Starbatty and F. Lefebvre for technical help. This work was supported by a Heisenberg grant of the Deutsche Forschungsgemeinschaft to T.E and by the Association Française contre les Myopathies, the Fondation pour la Recherche Médicale, and the Ministère de la Recherche et de l'Enseignement Supérieur (ACC-SV9).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vandecasteele, G., Eschenhagen, T., Scholz, H. et al. Muscarinic and β-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase. Nat Med 5, 331–334 (1999). https://doi.org/10.1038/6553
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/6553
This article is cited by
-
Generation and maturation of human iPSC-derived 3D organotypic cardiac microtissues in long-term culture
Scientific Reports (2022)
-
Rat atrial engineered heart tissue: a new in vitro model to study atrial biology
Basic Research in Cardiology (2018)
-
A concise discussion of the regulatory role of cGMP kinase I in cardiac physiology and pathology
Basic Research in Cardiology (2018)
-
Cardiac arrhythmia induced by genetic silencing of ‘funny’ (f) channels is rescued by GIRK4 inactivation
Nature Communications (2014)
-
Prostaglandin E2 does not attenuate adrenergic-induced cardiac contractile response
Naunyn-Schmiedeberg's Archives of Pharmacology (2014)